Indian researchers identify PIK3CA, ESR1, and TP53 mutations driving ER+ breast cancer resistance, paving the way for genetic testing and targeted therapies
19/02/2025 (UTC)
22/02/2025 (UTC)
16/02/2025 (UTC)
Don't miss out on life-changing opportunities! Our curated database features:
Join thousands of researchers who've advanced their careers through our platform!
Log in to create free customized alerts based on your prefernces